small cell neuroendocrine carcinoma lung icd 9

... “Composite” tumor– mixed squamous cell and small- cell anaplastic carcinoma of the larynx. Otolaryngol Head Neck Surg 198 6, 95 :99 -103. 5. Gnepp DR: Small cell neuroendocrine carcinoma of the larynx. A ... Otorhinolaryngol Relat Spec 199 1, 53:210-2 19. 6. Noske A, Pahl S: Combined adenosquamous and large -cell neuroendocrine carcinoma of the gallbladder. Virchows Arch 2006, 4 49: 135-136. 7. Yazawa T, Ishii ... Oncology 2010, 8 :92 http://www.wjso.com/content/8/1 /92 Page 4 of 5 CAS E REP O R T Open Access A colliding maxillary sinus cancer of adenosquamous carcinoma and small cell neuroendocrine carcinoma...

Ngày tải lên: 09/08/2014, 03:22

Ngày tải lên: 10/08/2014, 09:22

Ngày tải lên: 10/08/2014, 09:22

Ngày tải lên: 11/08/2014, 12:20

... with mitomycin, vindesine, and cisplatin in unresectable stage III non -small cell lung cancer. J Clin Oncol 199 9, 17:2 692 -9. 4. Gandara DR, Chansky K, Albain KS, et al: Long-term survival with concurrent ... Non -small- cell lung cancer: Cancer and Leukemia Group B. J Clin Oncol 2007, 25:1 698 -704. 9. Belani CP, Barstis J, Perry MC, et al: Multicenter, randomized trial for stage IIIB or IV non -small cell ... second-line treatment in patients with locally advanced or metastatic non -small- cell lung cancer. Ann Oncol 2008, 19: 9 39- 45. doi:10.1186/1748-717X-6-17 Cite this article as: Shen et al.: Phase...

Ngày tải lên: 09/08/2014, 09:20

Ngày tải lên: 09/08/2014, 09:20

Ngày tải lên: 10/08/2014, 10:20

Ngày tải lên: 10/08/2014, 10:21

Ngày tải lên: 11/08/2014, 21:22

... the key statistics about lung cancer? Most lung cancer statistics include both small cell and non -small cell lung cancers. Lung cancer (both small cell and non -small cell) is the second most ... diagnosed with non -small cell lung cancer between 199 8 and 2000. Stage 5-year Survival Rate IA 49% IB 45% IIA 30% IIB 31% IIIA 14% IIIB 5% IV 1% How is non -small cell lung cancer treated? ... prognosis than small cell or non -small cell lung cancer. Less common are atypical carcinoid tumors. The outlook for these tumors is somewhere in between typical carcinoids and small cell lung cancer....

Ngày tải lên: 15/03/2014, 00:20

... randomized clinical tri- als. BMJ 199 5, 311: 899 -90 9. 3. Bunn PA, Kelly K: New chemotherapeutic agents prolong sur- vival and improve quality of life in non -small cell lung cancer: a review of the literature ... J: Front-line treatment of advanced non -small- cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial. J Clin Oncol 199 9, 17 :91 4 -92 0. 23. Rebattu P, Quantin X, Ardiet C, ... advanced non -small- cell lung cancer: a phase III trial of the European Organiza- tion for Research and Treatment of Cancer Lung Cancer Group – EORTC 0 897 5. J Clin Oncol 2003, 21: 390 9- 391 7. 15. Gasperi-Campani...

Ngày tải lên: 18/06/2014, 15:20

... sensitivity overall 92 % delE746-A750 Ab 63% 22.86% 81.1% 99 % 84.6% 79% l858r Ab 100% 75% 97 % 95 .2% 83% IHC specificity overall 99 % delE746-A750 Ab 100% 92 % 100% 40% 98 .8% L858R Ab 100% 96 .6% 36% 98 .8% Simonetti ... classifi- cation [13]: 5 un differentiated large cell carcinomas and 3 small cell neuroendocrine carcinomas, 1 squamous cell carcinoma and 69 adenocarcinomas, of which 55 showed a single pattern ... smoker 7 9 Never smoker 45 58 Histology Adenocarcinoma 69 88.4 Large -cell carcinoma 5 7.1 Squamous cell carcinoma 1 1.4 Others 3 4.3 Adenocarcinoma subtype Glandular 36 52.2 Solid 20 29 Papillary...

Ngày tải lên: 18/06/2014, 16:20

... Mol Biol Cell 2008, 19: 3263-3271. doi:10.1186/14 79- 5876 -9- 2 Cite this article as: Buonomo et al.: Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced ... murine small cell lung carcinoma cell lines derived from HPV-16 E6/E7 transgenic mice. Cancer Lett 2006, 231:65-73. 17. Bélanger MM, Roussel E, Couet J: Caveolin-1 is down-regulated in human lung carcinoma ... are often divided into two broad categories: small cell lung cancer (SCLC) and non -small cell lung cancer (NSCLC). All major histological types of lung cancer are associated with smoking, although...

Ngày tải lên: 18/06/2014, 16:20

... 48 190 59 High 158 47 84 58 Missing 15 5 SCC (n = 191 ) NS Low 89 47 133 64 0.88 High 98 51 120 68 Missing 4 2 SCC, N0 0.15 NS Low 59 47 160 79 High 68 53 1 29 67 SCC, N+ 0.034 Low 30 50 49 32 High ... expression of miR-155. Results: There were 191 squamous cell carcinomas (SCCs), 95 adenocarcinomas (ACs), 31 large cell carcinomas and 18 bronchioalveolar carcinomas. MiR-155 expression did not have ... comprised 191 squamous cell carcinomas (SCCs), 95 adenocarcinomas (ACs), 31 large cell carcino- mas and 18 bronchioloalveolar carcinomas. Due to nodal metastasis or non-radical surgical margins, 59 (18%) patients...

Ngày tải lên: 18/06/2014, 16:20

... <0.0001 Progressive -0.1 798 0.021 69 99 -8. 29 <0.0001 Response 0.0 193 0.006556 99 2 .94 0.004 Stable 0 . . . . Neutropenia -0.0 897 3 0.01543 99 -5.82 <0.0001 Febrile Neutropenia -0. 090 02 0.01633 99 -5.51 <0.0001 Fatigue ... 0.018 49 99 -3 .97 0.0001 Nausea & vomiting -0.04802 0.01618 99 -2 .97 0.0038 Diarrhoea -0.0468 0.01553 99 -3.01 0.0033 Hair loss -0.04 495 0.01482 99 -3.03 0.0031 Rash -0.03248 0.01171 99 -2.77 ... Staging of small cell and non -small cell lung cancer. University of Iowa Virtual Hos- pital; 199 9. 6. Hopwood P, Stephens RJ: Symptoms at presentation for treat- ment in patients with lung cancer:...

Ngày tải lên: 18/06/2014, 19:20

... re- sponse( 79) 0 ~99 Negative 100~ 199 40% 200~ 299 100 Positive 300~400 58% EGFR protein status is associ- ated with gefitinib treatment response (23) 0 ~99 Negative 100~ 199 39% 200~ 299 200 ... ZD18 39) in non -small- cell lung can- cer. Br J Cancer. 2004; 91 (2): 208-12. 89. Bailey R, Kris M, Wolf M. Gefitinib (Iressa, ZD 18 39) mono- therapy for pretreated advanced non -small cell lung cancer ... 2007; 6(4): 1223 -9. 95 . Datta SR, Dudek H, Tao X, et al. Akt phosphorylation of BAD couples survival signals to the cell- intrinsic death machinery. Cell. 199 7; 91 (2): 231-41. 96 . Cardone MH,...

Ngày tải lên: 08/08/2014, 17:20

... continue treatment. Introduction In non -small cell lung cancer (NSCLC), mediastinal lymphnode involvement comprises a wide spectrum of severity. In fact, while 9% of patients with IIIA-N2 NSCLC is ... Carteni’ 1 Abstract Background: Defining the optimal treatment for patients with inoperable non small cell lung cancer (NSCLC), presenting with metastatic mediastinal lymph nodes, is challenging. Nevertheless, ... induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer Ferdinando Riccardi 1* , Giuseppe Di Lorenzo 1 , Carlo Buonerba 1 , Guglielmo...

Ngày tải lên: 09/08/2014, 03:21

... recurrent small cell neuroendocrine carcinoma of the rectum: report of a case. Surgery today 199 9, 29( 2):165 -9. doi:10.1186/1477-78 19- 8-100 Cite this article as: Kosmidis et al.: Small cell carcinoma ... 198 7, 18(1) :9- 21. 10. Yaziji H, Broghamer W: Primary small cell undifferentiated carcinoma of the rectum associated with ulcerative colitis. Southern Medical Journal 199 6, 89( 9) -92 1. 11. Chejfec ... Foundation 2008, 29( 4):224-6. 8. Rubin A, Pandya PP: Small cell neuroendocrine carcinoma of the rectum associated with chronic ulcerative colitis. Histopathology 199 0, 16(1) :95 -7. 9. Wick MR, Weatherby...

Ngày tải lên: 09/08/2014, 03:23

... per- formed. Discussion Undifferentiated small cell carcinoma (SCC) is an aggres- sive lung tumour accounting for 15% of all lung cancers [1]. Extrapulmonary small cell carcinomas (ESC) in com- parison ... purposes) keeping with a neuroendocrine carcinoma of small cell type. In the absence of an identified pulmonary tumour, a diagnosis of primary appendiceal small cell carcinoma was made. She made ... primary small cell carcinoma of her appendix. Conclusion: This is the first reported case of a pure extrapulmonary carcinoma arising from the appendix. Background Extrapulmonary small cell carcinomas...

Ngày tải lên: 09/08/2014, 07:21

... 18.15% (9. 46-31.08%) = 18. 59, SD = 6.03 = 28.02, SD = 7. 09 0.002 V25 12 .96 % (5 .90 -26.26%) = 12.88, SD = 4.42 = 20 .91 , SD = 6 .98 0.001 V30 10.00% (4.68-21.43%) = 9. 72, SD = 3.45 = 15. 69, SD = ... SD = 6.00 0.008 V35 9. 92% (3. 89- 18.65%) = 7.57, SD = 2.86 = 11 .95 , SD = 4.64 0.011 V40 8.20% (3. 29- 13.61%) = 5 .91 , SD = 2.48 = 9. 26, SD = 3.75 0.015 V45 7.42% (2.73-10 .99 %) = 4.41, SD = 2.25 ... with mitomycin, vindesine, and cisplatin in unresectable stage III non -small- cell lung cancer. J Clin Oncol 199 9, 17:2 692 -2 699 . 3. Komaki R, Seiferheld W, Curran W, Langer C, Lee J, Hauser S, Movasas...

Ngày tải lên: 09/08/2014, 08:23